Randomised Controlled TrialtaVNSn = 59

Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study

Zhang Y, Huang Y, Li H, Yan Z, Zhang Y, Liu X, Hou X, Chen W, Tu Y, Hodges S, et al.

Regional Anesthesia & Pain Medicine · 2021

Key finding

Of the 59 patients that finished the study, those in the taVNS group had significantly reduced number of migraine days, pain intensity and migraine attack times after 4 weeks of treatment compared with the sham taVNS.

Condition
Migraine
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
59
View on DOI

Cite this study

Zhang, Y., Huang, Y., Li, H., Yan, Z., Zhang, Y., Liu, X., Hou, X., Chen, W., Tu, Y., Hodges, S., Chen, H., Liu, B., & Kong, J. (2021). Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study. Regional Anesthesia & Pain Medicine, 46(2), 145-150. https://doi.org/10.1136/rapm-2020-102088

Related studies in Migraine

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.